KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Gross Profit (2020 - 2025)

Vir Biotechnology (VIR) has disclosed Gross Profit for 6 consecutive years, with $1.2 million as the latest value for Q2 2025.

  • Quarterly Gross Profit fell 60.21% to $1.2 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $18.3 million through Jun 2025, down 75.08% year-over-year, with the annual reading at $68.5 million for FY2025, 6.58% down from the prior year.
  • Gross Profit hit $1.2 million in Q2 2025 for Vir Biotechnology, down from $3.0 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $1.1 billion in Q1 2022 to a low of $1.2 million in Q2 2025.
  • Historically, Gross Profit has averaged $151.5 million across 5 years, with a median of $14.3 million in 2022.
  • Biggest five-year swings in Gross Profit: skyrocketed 57709.21% in 2022 and later tumbled 99.26% in 2023.
  • Year by year, Gross Profit stood at $755.9 million in 2021, then tumbled by 94.26% to $43.4 million in 2022, then plummeted by 63.17% to $16.0 million in 2023, then dropped by 26.89% to $11.7 million in 2024, then plummeted by 89.71% to $1.2 million in 2025.
  • Business Quant data shows Gross Profit for VIR at $1.2 million in Q2 2025, $3.0 million in Q1 2025, and $11.7 million in Q4 2024.